Thu, Apr 17, 2014, 3:41 PM EDT - U.S. Markets close in 19 mins.


% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • zorrelak69 zorrelak69 Mar 19, 2010 11:07 PM Flag

    CLDX Valuation

    They are not paying for any development costs related to CDX-110. The market value of this company makes no sense.

    Assuming they receive FDA approval of their brain cancer vaccine, they will receive $390 million in milestone payments as well as double digit royalties. Yet the market capitalization is only $170 million. Could anyone explain why investors are discounting the stock so much?

    It is apparent that it works in all trials. Some patients even survived as long as 6 years!

    Does anyone know the break-up of when we receive milestone payments? Is the full $390 upon FDA approval, or are some related to Phase II, Phase III completion?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
14.35-0.34(-2.31%)3:41 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.